Skip to content

Effects of motilitone on the improvement of dyspeptic symptoms in patients with depression and anxiety disorder comorbid with dyspepsia

Effects of motilitone on the improvement of dyspeptic symptoms in patients with depression and anxiety disorder comorbid with dyspepsia: double-blind, randomized, placebo controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0004973
Enrollment
50
Registered
2020-04-28
Start date
2020-05-04
Completion date
Unknown
Last updated
2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Wonkwang University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - 19 to 70 years old. - Patients diagnosed with depression or anxiety disorder by a psychiatrist (DSM5 diagnosis criteria) - Patients diagnosed with functional indigestion by a gastrointestinal surgeon (Rome IV createria)

Exclusion criteria

Exclusion criteria: - Patients whose substrate gastrointestinal diseases have been identified through gastroscopy - A person who has undergone surgery that can affect gastrointestinal motion or a patient with a history of gastrointestinal surgery - Patients who do not understand the purpose of this study - Patients who have participated in a gastrointestinal drug clinical trial within the last three months - Pregnant women, breastfeeding women and women in childbearing age who do not use proper contraception methods - use of benzodiazepines, sleeping fill, etc. is permitted under conditions of constant capacity during clinical trials. - Serious active medical conditions that may affect the quality of life scale are excluded. These include thyroid and adrenal cortical holmon diseases, consumptive or infectious diseases, active cancer diseases, chronic rheumatoid and autoimmune diseases, hepatitis and liver cirrhosis, acute heart failure or myocardial infarction, and acute respiratory diseases.

Design outcomes

Primary

MeasureTime frame
Nepean Dyspepsia Index(NDI) Questionnaire

Secondary

MeasureTime frame
Overall treatment effect(OTE) Index;Sheehan Disability Scale Index;Gastric Emptying Index

Countries

Korea, Republic of

Contacts

Public ContactSangYeol Lee

Wonkwang University Hospital

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026